IP Verse

Kernebeck patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Kernebeck opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kernebeck

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP2662094	Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors	ONYX THERAPEUTICS	Jan 17, 2025	STADA ARZNEIMITTEL
EP3781132	Apixaban Formulations	PFIZER	Dec 19, 2024	STADA ARZNEIMITTEL
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 17, 2024	STADA ARZNEIMITTEL
EP3500299	Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers	BEIGENE SWITZERLAND	Sep 13, 2024	KERNEBECK PATENTANWALTS
EP3782612	Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof	CELGENE	Aug 8, 2024	STADA ARZNEIMITTEL
EP3996688	Pharmaceutical Preparation	MERCK PATENT	Jun 6, 2024	STADA ARZNEIMITTEL
EP3067043	Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor	NOVARTIS	Aug 29, 2023	STADA ARZNEIMITTEL
EP2981255	Therapeutic Uses Of Empagliflozin	BOEHRINGER INGELHEIM	Jun 13, 2023	STADA ARZNEIMITTEL
EP2397142	Use Of Dpp Iv Inhibitors	BOEHRINGER INGELHEIM	Apr 26, 2023	STADA ARZNEIMITTEL
EP3782611	Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof	CELGENE	Apr 6, 2023	STADA ARZNEIMITTEL

Top companies who are the clients of Kernebeck

Company	Total
STADA ARZNEIMITTEL	29
KERNEBECK PATENTANWALTS	1